Omicron’s ability to evade antibodies does not impair ability to bind to cells

The video discusses a study from the journal Science on a variant capable of breakthrough infections affecting both vaccinated individuals and those previously infected. The variant's infectiousness is linked to 37 mutations in its spike protein, which help it evade antibodies from vaccines and monoclonal treatments. Despite expectations of a trade-off in binding ability, the study reveals that the variant's receptor binding domain has enhanced binding to human cells, while its interaction with antibodies is reduced.

What techniques were used in the study to analyze the Omicron spike protein?

In what way does the Omicron variant enhance its ability to bind to human cells?